By emphasizing its metabolic regulation, prognostic significance, and enrichment in cancer cells and CSCs, this study provides a foundation for future work exploring BMP4 as both a biomarker and a therapeutic target in pancreatic cancer. The gene discussed is BMP4; the disease is familial pancreatic carcinoma.